Healthy Females Clinical Trial
Official title:
Use of Indicator Amino Acid Oxidation Technique to Determine Protein Requirement of Elderly Female Subjects >75 Years Old
| Verified date | January 2018 |
| Source | The Hospital for Sick Children |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Minimal data are available on protein requirements throughout the lifespan. Currently
available recommendations are based on nitrogen balance data. The limitations of the nitrogen
balance method have been well described. Importantly, nitrogen balanced underestimates
requirements.
The current DRI requirement for healthy adult males is based on the reanalysis of the
nitrogen balance date from Young and Scrimshaw. This data was reanalyzed statistically by
Rand et al. and he concluded that the protein requirement of healthy adults was 0.65 and 0.83
(mean and RDA) g/kg/day of good quality protein. Using IAAO, the investigators group
estimated the protein requirement of young men (mean age 27 years) to be 0.93 and 1.2
g/kg/day (mean and RDA).
Currently there are no studies on protein requirement in the elderly. In a recent nutrition
survey conducted by NHANES, the authors concluded that adults between the ages of 51 - 70
years old consumed an average on 1.0 g/kg/day (ideal body weight) of protein which represents
about 15 % of calories. Depending on the calculations used for ideal body weight some older
adults could be getting higher or lower than requirement. There is no scientifically derived
protein estimate for older adults. Therefore there is a need to measurer protein requirement
in that population.
The goal of this study therefore is to measure the protein requirement of female elderly
subjects >75 years using the IAAO technique.
| Status | Completed |
| Enrollment | 14 |
| Est. completion date | December 2012 |
| Est. primary completion date | December 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Female |
| Age group | 76 Years to 90 Years |
| Eligibility |
Inclusion Criteria: 1. Healthy elderly females >75 years 2. Willingness to participate in the study 3. Females without a chronic disease or acute illness that could affect protein and AA metabolism eg, diabetes, cancer, liver or kidney disease, HIV, acute cold or flu, hypo or hyperthyroidism, rheumatoid arthritis treated with anti-inflammatory medications. 4. Females with hypertension if well controlled by medications - Exclusion Criteria: 1. Presence of disease known to affect protein and AA requirement and synthesis like diabetes, cancer, liver o kidney disease, HIV, acute cold or flu, hypo or hyperthyroidism, rheumatoid arthritis treated with anti-inflammatory medications. 2. On medications known to affect protein and amino acid metabolism like e.g. steroids. 3. Significant weight loss during the past month. 4. Individual on weight reducing diets. 5. Inability to tolerate the diet or unwilling to have blood drawn from a venous access for the purposes of the study. 6. Significant coffee consumption of more than 2 cups/day (400 mg of caffeine/day) 7. Significant Alcohol consumption of more than one drink/day ( 1 beer, ½ glass of wine) - |
| Country | Name | City | State |
|---|---|---|---|
| Canada | The Hospital for Sick Children | Toronto | Ontario |
| Lead Sponsor | Collaborator |
|---|---|
| The Hospital for Sick Children | Canadian Institutes of Health Research (CIHR) |
Canada,
Rafii M, Chapman K, Owens J, Elango R, Campbell WW, Ball RO, Pencharz PB, Courtney-Martin G. Dietary protein requirement of female adults >65 years determined by the indicator amino acid oxidation technique is higher than current recommendations. J Nutr. 2015 Jan;145(1):18-24. doi: 10.3945/jn.114.197517. Epub 2014 Oct 15. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | 13CO2 Production | Urine and breath samples will be collected on day 3 of the experiment to determine the rate of production | Study Day 3 |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03662516 -
A Study to Determine the Effects of PF-04965842 on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Subjects
|
Phase 1 | |
| Completed |
NCT03608241 -
A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
|
Phase 1 | |
| Completed |
NCT05738733 -
A Clinical Efficacy Study of MsChief Personal Lubricant in Healthy Female Subjects
|
N/A |